GM
49
2
GS
49
-9
BA
56
2
SWKS
51
6
MMM
32
6
SPG
43
2
BXP
34
-4
AIG
32
3
VFC
50
-4
BWA
40
2
ALLE
16
-3
KIM
56
12
OXY
26
-10
ETR
60
6
FLS
61
5
WEC
36
5
GME
59
3
AA
21
-11
FLR
38
2
JWN
63
8
GM
49
2
GS
49
-9
BA
56
2
SWKS
51
6
MMM
32
6
SPG
43
2
BXP
34
-4
AIG
32
3
VFC
50
-4
BWA
40
2
ALLE
16
-3
KIM
56
12
OXY
26
-10
ETR
60
6
FLS
61
5
WEC
36
5
GME
59
3
AA
21
-11
FLR
38
2
JWN
63
8
Financhill
Back

Applied DNA Sciences 10K Form

Sell
27

APDN
Applied DNA Sciences

Last Price:
$0.19
Seasonality Move:
-2.43%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2023-08-10 10Q APDN/Applied DNA Sciences Quarterly
2023-05-11 10Q APDN/Applied DNA Sciences Quarterly
2023-02-09 10Q APDN/Applied DNA Sciences Quarterly
2022-08-11 10Q APDN/Applied DNA Sciences Quarterly
2022-05-12 10Q APDN/Applied DNA Sciences Quarterly
2022-02-10 10Q APDN/Applied DNA Sciences Quarterly

Receive APDN News And Ratings

See the #1 stock for the next 7 days that we like better than APDN

APDN Financial Statistics

Sales & Book Value

Annual Sales: $13.4M
Cash Flow: $-3.5M
Price / Cash Flow: 0
Annual Sales: $1.20
Price / Book: 0.79

Profitability

EPS (TTM): -11.99000
Net Income (TTM): $-7.3M
Gross Margin: $5.5M
Return on Equity: -128.97%
Return on Assets: -55.87%

Applied DNA Sciences Earnings Forecast

Key Applied DNA Sciences Financial Ratios

  • The Gross Profit Margin over the past 18 years for APDN is 41.39%.
  • The Selling, General & Administrative Expenses for APDN have been equal to 95.39% of Gross Profit Margin.
  • The Research & Development expenses have been 27.94% of Revenue.
  • The Interest Expense is -0.92% of Operating Income.
  • The Net Earning history of APDN is -74.41% of Total Revenues.
  • Per Share Earnings over the last 26 years have been positive in 16 years.

Applied DNA Sciences Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Life Sciences Tools & Services
Sector: Health Care
Current Symbol: APDN
CUSIP: 03815U
Website: adnas.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 3.91
Quick Ratio: 3.62

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

APDN Technical Analysis vs Fundamental Analysis

Sell
27
Applied DNA Sciences (APDN) is a Sell

Is Applied DNA Sciences a Buy or a Sell?